Pharma & Healthcare – the latest on the FDA quality requirements, J&J $12.5M gamble and more.
The Euro 1.3-billion Dutch company,
IMCD Group BV, is one of the leading distributors of speciality chemicals, representing major global producers and offering solutions for customers’ problems utilising its comprehensive and complementary product portfolio…
[ Read More ]
Later this week a little biotech named Capricor Therapeutics is set to begin a Phase II study of its new stem cell therapy with about $20 million in support from the
California Institute for Regenerative Medicine (CIRM). And this morning Johnson & Johnson (
$JNJ) is stepping up with a $12.5 million upfront to buy itself an option and a front-row seat on the program–marking a rare Big Pharma gamble on a field that is trying hard to mount a comeback… [
Read More ]
In its continuing effort to safeguard expenditures of taxpayer dollars, the United States Justice Department has reported a 2013 recovery of $3.8 billion in settlements and judgments resolving a myriad of whistleblower lawsuits and False Claims Act cases. Cases involving health care fraud comprised more than one-half of the total reported recovery, or $2.6 million…. [
Read More ]
Live Industry News
Follow
@ACI_Pharma
Join
ACI Pharmaceuticals/Biotech/Life Sciences Experts Group
Related Events
For the complete list of all Pharma upcoming events:
Click Here
For the complete list of all Healthcare upcoming events:
Click Here
To download past Pharma conference materials:
Click Here
To download past Healthcare conference materials:
Click Here Tags: Controlled Substances, Long Term Care, Weekly Industry News